Off-Label, Off-Limits?

TREAD CAREFULLY when it comes to off-label discussion: That was the message that came through loud and clear in a 90-minute audioconference called, “Off-Label: Compliance Lessons for Marketing, Sales, and Medical Science Liaisons,” held in early March by HCPro, Marblehead, Mass. As presenter Jane Chin, PhD, said, today's regulatory and legal climate “gives a new meaning to ‘clinical trial.’ Now it's clinical trial by jury.” Chin is president, Medical Science Liaison Institute, and